Peter Stumbles is a partner at Financial solutions based in the Sydney office. He is the head of the Asia-Pacific Financial Services practice and is also a leader in the Global Performance Improvement practice.
Egypt is currently witnessing a rapid and ongoing development in all industrial fields and we can never imagine a developed society that is not making the pharmaceutical industry one of its priorities. Pharmaceutical products represent one of the four essential requirements in human life, namely: food, housing, clothing and medicine.
I believe that this is the time we talk about a new phase in the history of pharmaceutical industry; particularly after the Egyptian Ministry of Health had made great developments in the field of pharmaceutical industry to improve the industry in a manner that enables Egypt to regain its post in the field, to obtain new patents and to confront the domination of the developed countries in the World Trade Organization (WTO) and World Intellectual Property Organization (WIPO), in addition to the development of Egyptian pharmaceutical factories in accordance with the international standards of quality in the USA through Food and Drug Administration (FDA) and the European Union represented in the European Medicines Evaluation Agency (EMEA).
